%0 Journal Article
%T The contrasting roles of PPAR¦Ä and PPAR¦Ã in regulating the metabolic switch between oxidation and storage of fats in white adipose tissue
%A Lee D Roberts
%A Andrew J Murray
%A David Menassa
%A Tom Ashmore
%A Andrew W Nicholls
%A Julian L Griffin
%J Genome Biology
%D 2011
%I BioMed Central
%R 10.1186/gb-2011-12-8-r75
%X The metabolic effects of PPAR¦Ã and PPAR¦Ä activation have been examined in vivo in white adipose tissue from ob/ob mice and in vitro in cultured 3T3-L1 adipocytes using 1H nuclear magnetic resonance spectroscopy and mass spectrometry metabolomics to understand the receptors' contrasting roles. These steady state measurements were supplemented with 13C-stable isotope substrate labeling to assess fluxes, in addition to respirometry and transcriptomic microarray analysis. The metabolic effects of the receptors were readily distinguished, with PPAR¦Ã activation characterized by increased fat storage, synthesis and elongation, while PPAR¦Ä activation caused increased fatty acid ¦Â-oxidation, tricarboxylic acid cycle rate and oxidation of extracellular branch chain amino acids. Stimulated glycolysis and increased fatty acid desaturation were common pathways for the agonists.PPAR¦Ã and PPAR¦Ä restore insulin sensitivity through varying mechanisms. PPAR¦Ä activation increases total oxidative metabolism in white adipose tissue, a tissue not traditionally thought of as oxidative. However, the increased metabolism of branch chain amino acids may provide a mechanism for muscle atrophy, which has been linked to activation of this nuclear receptor. PPAR¦Ä has a role as an anti-obesity target and as an anti-diabetic, and hence may target both the cause and consequences of dyslipidemia.The World Health Organization estimates over 180 million people worldwide suffer from type 2 diabetes mellitus (T2DM). The incidence of obesity, a major risk factor for the development of T2DM, is also increasing globally. While a number of anti-diabetic treatments have been produced, they rarely address the related obese state and consequently fail to confront this underlying risk factor. Therefore, it becomes imperative that new treatment approaches with both anti-diabetic and anti-obesity properties are found.The peroxisome proliferator-activated receptors (PPARs) are ligand activated transcription factor
%U http://genomebiology.com/2011/12/8/R75